In a recent study, a label-free electrochemical biosensing system was developed for the sensitive detection of epidermal growth factor receptor (EGFR), a protein frequently overexpressed in various cancers, including lung cancer, breast cancer, and GBM. This evidence concerns the gene EGFR and glioblastoma.